Histological recurrence of autoimmune liver diseases after living-donor liver transplantation

Hepatology Research

Volumn 37, Issue SUPPL. 3, 2007, Pages

  Haga, Hironori ^a   Miyagawa Hayashino, Aya ^a   Taira, Kaoru ^b   Morioka, Daisuke ^b,c   Egawa, Hiroto ^b   Takada, Yasutsugu ^a   Manabe, Toshiaki ^a   Uemoto, Shinji ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Human leukocyte antigen; Livingdonor liver transplantation; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

ANTIMETABOLITE; HLA DR15 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; AUTOIMMUNE DISEASE; CONFERENCE PAPER; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROPERITONEAL FIBROSIS; SURVIVAL TIME; ULCERATIVE COLITIS;

EID: 35348844589     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00245.x     Document Type: Conference Paper

References (32)

1. Faust TW. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation. Liver Transpl 2001; 7 (11 Suppl 1): S99-108.
2. Neuberger J. Recurrent primary biliary cirrhosis. Liver Transpl 2003; 9: 539-46.
3. Bjoro K, Brandsaeter B, Foss A, Schrumpf E. Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 2006; 26: 69-79.
4. Banff Working Group: Demetris AJ, Adeyi O, Bellamy CO et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489-501.
5. Tsuji K, Watanabe Y, Van De Water J et al. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 1999; 13: 171-8.
6. Bergquist A, Lindberg G, Saarinen S, Broome U. Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 2005; 42: 252-6.
7. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994; 20: 698-701.
8. Morioka D, Egawa H, Kasahara M et al. Impact of humal leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 80-90.
9. Yuasa T, Tsuji H, Kimura S et al. Human leukocyte antigens in Japanese patients with biliary atresia: Retrospective analysis of patients who underwent living donor liver transplantation. Hum Immunol 2005; 66: 295-300.
10. International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-63.
11. Demetris A, Adams D, Bellamy C et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panes. Hepatology 2000; 31: 792-9.
12. Demetris AJ, Nakamura K, Yagihashi A et al. A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology 1992; 16: 671-81.
13. Haga H, Egawa H, Shirase T et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004; 10: 16-27.
14. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967; 60: 1257-60.
15. Graziadei IW, Wiesner RH, Marotta PJ et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 1121-7.
16. Hashimoto E, Shimada M, Noguchi S et al. Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow-up study. Liver Transpl 2001; 7: 588-95.
17. Hasegawa K, Sugawara Y, Imamura H, Ikeda M, Kokudo N, Makuuchi M. Living donor liver transplantation for primary biliary cirrhosis: Retrospective analysis of 50 patients in a single center. Transpl Int 2005; 18: 794-9.
18. Tsunematsu I, Ogura Y, Inoue K, Koizumi A, Tanigawa N, Tanaka K. Quantitative survival model for short-term survival after adult-to-adult living donor liver transplantation. Liver Transpl 2006; 12: 904-11.
19. Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis. Retrospective analysis of 400 patients in a single center. Hepatology 2001; 33: 22-7.
20. Inomata Y, Tanaka K, Egawa H et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247-52.
21. Masuda S, Goto M, Fukatsu S et al. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients. Clin Pharmacol Ther 2006; 79: 90-102.
22. Seiler CA, Dufour JF, Renner EL et al. Primary liver disease as a determinant for acute rejection after liver transplantation. Langenbecks Arch Surg 1999; 384: 259-63.
23. Farges O, Saliba F, Farhamant H et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: Possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996; 23: 240-8.
24. Sylvestre PB, Batts KP, Burgart LJ, Poterucha JJ, Wiesner RH. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Liver Transpl 2003; 9: 1086-93.
25. Tsuji K, Watanabe Y, Kouno H et al. A case of latent primary biliary cirrhosis. Hepatol Res 2004; 28: 166-9.
26. Khettry U, Keaveny A, Goldar-Najafi A et al. Liver transplantation for primary sclerosing cholangitis: A long-term clinicopathologic study. Hum Pathol 2003; 34: 1127-36.
27. Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995; 19: 81-90.
28. Yabushita K, Yamamoto K, Ibuki N et al. Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis. Liver 2001; 21: 50-5.
29. Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 2002; 35: 555-64.
30. Zen Y, Harada K, Sasaki M et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: Do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004; 28: 1193-203.
31. Fukui T, Okazaki K, Yoshizawa H et al. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren's syndrome. Pancreatology 2005; 5: 86-91.
32. Hasegawa Y, Kawachi S, Simazu M et al. Discontinuation of living donor liver transplantation for PSC due to histological abnormalities in intraoperative donor liver biopsy. Am J Transplant 2007 Jul 5; [Epub ahead of print].